Concepedia

Publication | Open Access

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

264

Citations

35

References

2016

Year

Abstract

NCT01582269, ClinicalTrials.gov.

References

YearCitations

Page 1